Candesartan in the treatment of hypertension: what have we learnt in the last decade?
about
Which thiazide to choose as add-on therapy for hypertension?An evaluation of the latest evidence relating to renin-angiotensin system inhibitors.Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?Candesartan targeting of angiotensin II type 1 receptor demonstrates benefits for hypertension in pregnancy via the NF‑κB signaling pathway.
P2860
Candesartan in the treatment of hypertension: what have we learnt in the last decade?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Candesartan in the treatment of hypertension: what have we learnt in the last decade?
@en
Candesartan in the treatment of hypertension: what have we learnt in the last decade?
@nl
type
label
Candesartan in the treatment of hypertension: what have we learnt in the last decade?
@en
Candesartan in the treatment of hypertension: what have we learnt in the last decade?
@nl
prefLabel
Candesartan in the treatment of hypertension: what have we learnt in the last decade?
@en
Candesartan in the treatment of hypertension: what have we learnt in the last decade?
@nl
P2860
P1476
Candesartan in the treatment of hypertension: what have we learnt in the last decade?
@en
P2093
Carlos Escobar
Vivencio Barrios
P2860
P304
P356
10.1517/14740338.2011.608064
P407
P577
2011-08-17T00:00:00Z